Ovarian cancer, historically challenging to diagnose due to vague early symptoms, often reaches advanced stages before ...

Results from a new Phase 3 trial published in the journal npj Precision Oncology found that a cancer stem cell test can ...

The grade of your cancer cells – which rates how much they look like healthy cells and can predict how they’ll act – plays a role. Epithelial ovarian cancers, which account for 90% of all ...

The most common surgical complications in obese patients with epithelial ovarian cancer (EOC) include wound infection, ...

Antibody-drug conjugates and their development remains a central theme in ongoing research within the realm of ovarian cancer ...

After you’ve gone through ovarian cancer treatment, your doctor will work with you to make sure you stay well. But sometimes the cancer returns. Doctors call this “recurrence.” To check for ...

Patients with advanced epithelial ovarian cancer who were non-Hispanic Black, older, had lower household income, resided in ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Patients in the pembrolizumab-olaparib arm had clinically meaningful improvements in PFS over patients in the control arm.

Standard therapy for newly diagnosed advanced epithelial ovarian cancer is cytoreductive surgery combined with paclitaxel-carboplatin chemotherapy with or without bevacizumab. In the phase II ...